Pham JC, Pronovost PJ, Skipper GE. Prevalence of Drug Testing Among Family Medicine Residents and Students: Much Needed Data. Journal of Graduate Medical Education March 2015, 128-130
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507906/
Gordon A, Jaffe A, McLellan AT, Richardson G, Skipper GE, Sucher M, Tirado CF, Urschel H. How Should Remote Clinical Monitoring Be Used to Treat Alcohol Use Disorders?: Initial Findings from an expert round table Discussion. J Addict Med, 2017 Mar/Apr;11(2):145-153 2016 • Merlo LJ, Campbell MD, Skipper GE, Shea CL, DuPont RL. Outcomes for Physicians With Opioid Dependence Treated without Agonist Pharmacotherapy in Physician Health Programs. JSAT 64 (2016) 47-54
https://www.ncbi.nlm.nih.gov/pubmed/28157829
Rose JS, Campbell MD, Yellowlees P, Skipper GE, DuPont DL. Family Medicine Physicians with Substance Use Disorder: A 5-Year Outcome Study. JAM 2016 6 pages 2015 • Yellowlees PM, Skipper GE, et al. Psychiatrists with Substance Use Disorders: Positive Treatment Outcomes From Physician Health Programs, Psychiatric Services in Advance, pgs. 1-4
https://ps.psychiatryonline.org/doi/abs/10.1176/appi.ps.201300472?code=ps-site
Skipper GE. The Impaired Professional Part III, Understanding Addicted Physicians, Counselor Magazine, October 2015, 17-18 2014 • Pham JC, Pronovost PJ, Skipper GE. California’s Proposition 46: A Wolf in Sheep’s Wool. Annals of IM, 16 December 2014, Vol 161(12), 913-914. https://issuu.com/hcibooks/docs/counselor_october_sneakpeek
DuPont RL, Shea CL, Skipper GE, et al. The New Paradigm for Recovery: Making Recovery – and Not Relapse – the Expected Outcome of Addiction Treatment. A White Paper Report of the John P McGovern Symposium. March 2014.
http://www.williamwhitepapers.com/pr/IBH%20Creating%20a%20New%20Standard%20for%20Addiction%20Treatment%20Outcomes%202014.pdf
Dammann G, Dursteler-MacFarland KM, Strasser H, Skipper GE, Wiesbeck GA, Wurst FM. Cannabis Use Among a Sample of 16 to 18 Year-old Students in Switzerland. Psychiatria Danubina, 2014:Vol.26, No. 1, pp56-65.
http://www.hdbp.org/psychiatria_danubina/pdf/dnb_vol26_no1/dnb_vol26_no1_56.pdf
Skipper GE, Thon N, DuPont RL, Campbell MD, Weinmann W, Wurst FM. Cellular Photo Digital Breathalyzer for Monitoring Alcohol Use: A Pilot Study. Eur Addict Res 2014:20:137-142. Curriculum Vitae: Gregory E. Skipper, M.D. 7 of 21 pages • Rose JS, Campbell M, Skipper GE. Prognosis for Emergency Room Physicians with Substance Abuse Recovery: 5 Year Outcome Study. Western Journal of Emergency Medicine. Vol XV, No 1, Feb 2014. 2013
https://www.ncbi.nlm.nih.gov/pubmed/24335415
Pham JC, Pronovost PJ, Skipper GE. Identification of Physician Impairment. JAMA. 2013;():1-2. doi:10.1001/jama.2013.4635. • Skipper GE. Substance Disorders: Best Practices in Drug and Alcohol Testing Across a Continuum of Care. Alere Toxicology. Monograph 2013.
https://www.ncbi.nlm.nih.gov/pubmed/23629590
Wurst FM, Rumpf HJ, Skipper GE, Allen JP, Kunz I, Beschoner P, Thon N. Estimating the prevalence of drinking problems among physicians. Gen Hosp Psychiatry. 2013 Jul 5. doi:pii: S0163-8343(13)00139-4. 10.1016/j.genhosppsych.2013.04.018. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/23835083
Skipper GE, Thon N, Dupont RL, Baxter L, Wurst FM. Phosphatidylethanol: The Potential Role in Further Evaluating Low Positive Urinary Ethyl Glucuronide and Ethyl Sulfate Results. Alcohol Clin Exp Res. 2013 Sep;37(9):1582-6 doi: 10.1111/acer.12121. June 3
https://www.ncbi.nlm.nih.gov/pubmed/23731162
Skipper GE. State Physician Health Programs Protect the Public – And Save Careers. Federation of State Physician Health Programs Newsletter. Feb 2013. Vol 18. Pgs. 4-5. 2012
http://www.fsphp.org/sites/default/files/pdfs/acfrogc0xziawry1re9ghkqebqwsy6upc9exddrgpg53k8xmy99yzsdzsw8n0yvptvq4autw25wds39kxvs80u8vxcdlauobj7a742mqraq7h504mtxkmn3r2v8xl-e.pdf
Skipper GE, Schenthal S. Special from Missouri Physicians Health Program. Sexual misconduct by professionals: a new paradigm of understanding. Mo Med. 2012 MayJun;109(3):184-6. No abstract available.
https://www.ncbi.nlm.nih.gov/pubmed/22860280
Dupont RL, Skipper GE. Six lessons from state physician health programs to promote long-term recovery. J Psychoactive Drugs. 2012 Jan-Mar;44(1):72-8.
https://www.ncbi.nlm.nih.gov/pubmed/22641968
Skipper GE, Williams J. Failure to Acknowledge High Suicide Risk among Veterinarians. Journal of Veterinary Medical Education, Issue 1, 2012, p.-1.
https://www.ncbi.nlm.nih.gov/pubmed/22433743
Skipper GE, DuPont R, Martin D. A New Challenge for Drug-Free Workplace Programs. Journal of Occupational Health and Safety. Occup Health Saf. 2012 Feb;81(2):32, 34. Curriculum Vitae: Gregory E. Skipper, M.D. 8 of 21 pages 2011
https://ohsonline.com/Articles/2012/02/01/A-New-Challenge-for-Drug-Free-Workplace-Programs.aspx
Skipper GE, DuPont RL. The Advantages of Long-Term Monitoring. Addiction Professional. July 2011.
www.addictionpro.com/article/advantages-long-term-monitoring
Wurst FM, Thon N, Yegles M, Halter C, Weinmann W, Laskowska B, Strasser J, Skipper G, Wiesbeck GA, Dursteler-Macfarland K. Optimizing heroin-assisted treatment (HAT): Assessment of the contribution of direct ethanol metabolites in identifying hazardous and harmful alcohol use. Drug Alcohol Depend. 2010 Dec 7. (Epub ahead of print)
https://www.ncbi.nlm.nih.gov/pubmed/21145180
Skipper GE, DuPont RL. The Physician Health Program: A Replicable Model of Sustained Recovery Management. (Chapter 17 pgs. 281-299) In: J.F. Kelly and W.L. White (eds.), Addiction Recovery Management: Theory, Research and Practice, Current Clinical Psychiatry, DOI 10.1007/978-1-60327-960-4_15, Springer Science+Business Media, LLC 2011
https://link.springer.com/chapter/10.1007/978-1-60327-960-4_15
Skipper GE, DuPont RL. US Physician Health Programs: A Model of Successful Treatment of Addictions. Counselor: The Magazine for Addiction Professionals. Dec 2010. Vol 11(6) 22-30.
Skipper GE. Medical Malpractice: Anatomy of a Lawsuit and Malpractice Stress Syndrome. Newsletter of the Missouri Physician Health Program. March 2010. Pgs. 2-8 2009
Skipper GE. Confrontational approach has no role in addressing physician addiction. Mayo Clin Proc. 2009 Nov;84(11):1042-3.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2770919/
Skipper GE. In Response to letter to the Editor. Anesthesia and Analgesia. Volume X. Number X. 2010, pg. 1
https://journals.lww.com/anesthesia-analgesia/fulltext/2015/05000/Anesthesiologists_and_Substance_Use_Disorders___An.41.aspx
Skipper GE. The value of physician health programs. Alabama Board of Medical Examiners Newsletter and Report. October – December 2009, Volume 24, Number 4, pgs. 1-4
http://www.albme.org/Documents/Newsletters/2009V24No4.pdf
Skipper GE, Campbell MD, DuPont RL. Anesthesiologists with Substance Use Disorders: A 5- Year Outcome Study from 16 State Physician Health Programs. Anesth & Analg 109(3), Sept 2009, 891-896.
https://www.ncbi.nlm.nih.gov/pubmed/19690263
Skipper GE, DuPont RL. Anesthesiologists Returning to Work after Substance Abuse Treatment. Anesthesiology, V110, No 6, June 2009 1426-28.
https://gregskippermd.weebly.com/uploads/7/4/7/5/74751/anesthesiologists_returning_to_work.anesthesiology.lte.skipper.only.pdf
DuPont RL, McLellan AT, Carr G, Gendel M, Skipper GE. How are addicted physicians treated? A national survey of physician health programs. JSAT 37 (2009) 1-7.
https://www.ncbi.nlm.nih.gov/pubmed/19482236
Skipper GE, DuPont RL. What about Physician Health Programs. The New Republic. January 18, 2009 Curriculum Vitae: Gregory E. Skipper, M.D. 9 of 21 pages
Skipper GE, Liepman M, Wurst FM, Weinmann W. Breathing Vapor of Ethanol-Based Hand Sanitizing Gel Vapor Causes Positive Alcohol Marker, Ethylglucuronide (EtG), and Positive Breathalyzer. (Accepted for publication by Journal of Addiction Medicine 11/25/2008)
https://gregskippermd.weebly.com/uploads/7/4/7/5/74751/ethgelpaperjam.pdf
Skipper GE, Schenthal SJ. Professional Sexual Misconduct: A new paradigm of understanding. Alabama Board of Medical Examiners Newsletter and Report, 23(3), July-Sept 2008, 1-6.
https://gregskippermd.weebly.com/uploads/7/4/7/5/74751/psm.albme.pdf
Physicians and Medical Workers, Substance Abuse Among. Encyclopedia of Drugs, Alcohol & Addictive Behavior, 3rd ed., Macmillan Reference USA, 2008, Vol 3, pages 242-251
McLellan AT, Skipper GE, Campbell M, DuPont RL. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ. 2008 Nov 4;a2038, doi:10.1136.a2038.
http://www.bmj.com/content/337/bmj.a2038
White, W.L., DuPont, R.L., Skipper, G.E. (2008). Physician health programs: What counselors can learn from these remarkable programs. Counselor Magazine, June 27, 2007, 44-51
http://www.williamwhitepapers.com/pr/2007PhysicianHealthPrograms.pdf
Skipper GE, DuPont RL, White WL. Testing for Recent Alcohol Use. Perspectives – the Journal of the American Probation and Parole Association. 2008(32)3, 38-45
http://www.williamwhitepapers.com/pr/2008RecentAlcoholTesting.pdf
DuPont RL, Skipper GE, White WL. Testing for Recent Alcohol Use. Student Assistance Journal. Spring 2008 12-18
http://www.williamwhitepapers.com/pr/2008RecentAlcoholTesting.pdf
DuPont RL, Skipper GE, White WL. Testing for Alcohol Use. Counselor Magazine. April 2008(9) 44-51. • DuPont, R.L., Skipper, G.E. & White, W. L. (2007). Testing for recent alcohol use. Employee Assistance Digest, Winter2007,28(1), 15-21 2006
https://www.researchgate.net/publication/265480652_Testing_For_Recent_Alcohol_Use
Skipper GE, Schenthal S. Professional Sexual Misconduct – A Primer. Published on the Web, www. Professionalboundaries.com 2005
http://www.themphp.org/Archive/Articles/tabid/98/ArticleID/214/Professional-Sexual-Misconduct-A-new-paradigm-of-understanding.aspx
Skipper GE, Brase DA. Tramadol Abuse and Dependence among Physicians. JAMA. 2005; 293:1977-1978 2004
https://www.ncbi.nlm.nih.gov/pubmed/15494578
Skipper GE, Fletcher C, Rocha-Judd R, Brase D. Tramadol Abuse and Dependence among Physicians. JAMA. 2004;292:1818-1819
Skipper GE, Weinmann W, Wurst FM. Ethylglucuronide (EtG): A New Marker to Detect Alcohol Use in Recovering Physicians. Journal of Medical Licensure and Discipline, 2004,90(2), 14-17
http://www.ushealthtests.com/etg-testing-for-recovering-physicians.pdf
Skipper GE, Weinmann W, Theirauf A, Schaefer P, Wiesbeck G, Allen JP, Miller M, Wurst FM. Ethyl Glucuronide: A Biomarker to Identify Alcohol use by Health Professionals Recovering from Substance Use Disorders, Alcohol Alcohol. 2004 Sep-Oct;39(5):445-9. Epub 2004 Aug 2. Curriculum Vitae: Gregory E. Skipper, M.D. 10 of 21 pages
https://academic.oup.com/alcalc/article/39/5/445/203846
Wurst FM, Alexson S, Skipper GE, Wiesbeck G, Wolfersdorf M, Marques P, Metzger J, Gilg T, Weinmann W (2004) Fatty acid ethyl esters, ethyl glucuronide and methanol in the serum of alcoholics during detoxification. Alcohol Clin Exp Res 28:157A
https://hero.epa.gov/hero/index.cfm/reference/details/reference_id/1156005
Skipper GE, Schaefer P, Thierauf A, Weinmann W, Allen JP, Miller M, Wiesbeck GA, Wurst F M (2004) Detection of Surreptitious Alcohol Use Among Health Professionals Recovering from Substance-Related Disorders Using a New Marker, Ethyl Glucuronide. Addiction (submitted 12/03; #03/427)
https://www.sciencedirect.com/science/article/pii/S1044030503007657
Wurst F M, Skipper GE, Weinmann W (2003) Ethyl glucuronide – the direct ethanol metabolite on the threshold from science to routine use. Addiction 98 (Suppl 2) 51-61
https://www.ncbi.nlm.nih.gov/pubmed/14984242
Wurst F M., Vogel R., Jachau K., Varga A., Alling C., Skipper G.E., Alt A. (2003) Ethyl glucuronide detects recent alcohol use in forensic psychiatric inpatients. Alcohol Clin Exp Res 27: 471-476
https://www.ncbi.nlm.nih.gov/pubmed/12658113
Journal highlight ACER 03/2003, Feature story: www.eurekalert.com. (American Association for the Advancement of Science)
https://etg.weebly.com/uploads/7/4/7/5/74751/etg_advisory.2005.09.pdf
Bell, Matthew C., Goldenberg, Matthew, McDevitt, Margaret A., The Influence of Intertrial Interval Food on Extinction and Devaluation in Chain Schedules, The Journal Of General Psychology, April, 2006. 134: 133-152.
https://www.ncbi.nlm.nih.gov/pubmed/17503691
Rashi Agarwal, MD, Matthew Goldenberg, DO, Robert Perry, MD, and Waguih William Ishak, MD, FAPA. The quality of life of adults with attention deficit hyperactivity disorder: a systematic review. Innovations in Clinical Neuroscience. 2012 May-Jun; 9(5-6): 10–21.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398685/
Fakhry H, Goldenberg M, Sayer G, Aye SS, Bagot K, Pi S, Ghazzaoui R, Vo N, Gowrinathan S, Bolton M, IsHak WW. Health Related Quality of Life in Childhood Cancer. Journal of Developmental & Behavioral Pediatrics. 2013 July/August;34(6):419-440.
https://journals.lww.com/jrnldbp/Abstract/2013/07000/Health_Related_Quality_of_Life_in_Childhood_Cancer.7.aspx
Matthew Goldenberg. A Psychiatric Perspective on Tobacco Use Disorder and Smoking Cessation. American Journal of Psychiatry-Residents’ Journal. February, 2014; 9 (2): 2.
https://ajp.psychiatryonline.org/pb/assets/raw/journals/residents-journal/2014/February_2014.pdf
Matt Goldenberg. Opioid Overdoses: A Guide to Stem the Tide. American Journal of Psychiatry-Residents’ Journal. September, 2014; 9 (9): 6.
https://ajp.psychiatryonline.org/pb/assets/raw/journals/residents-journal/2014/Sept_2014.pdf
Matthew Goldenberg, I Danovitch, WW IsHak. Quality of Life and Smoking. The American Journal on Addictions. Volume 23, Issue 6, pages 540–562, November-December 2014
https://www.ncbi.nlm.nih.gov/pubmed/25255868
Goldenberg M, Hassamal S, IsHak WW, Haglund M, Miotto K, Danovitch I. A Call to Action: The Active Role Psychiatrists and the DEA Must Take to Decrease Harm from Psychotropic Drugs Acquired via the Internet. J Clin Psychiatry. 2016 Nov;77(11)
https://www.ncbi.nlm.nih.gov/pubmed/28076677
Danovitch I, Steiner AJ, Kazdan A, Goldenberg M, Haglund M, Mirocha J, Collison K, Vanle B, Dang J, IsHak WW. Analysis of Patient-reported Outcomes of Quality of Life and Functioning Before and After Treatment of Major Depressive Disorder Comorbid With Alcohol Use Disorders. J Addict Med. Jan/Feb 2017; 11 (1), 47-54.
https://www.ncbi.nlm.nih.gov/pubmed/27763941
Hassmal S, Goldenberg M, IsHak WW, Haglund M, Miotto K, Danovitch I. Overcoming Barriers to Initiating Medication Assisted Treatment for Heroin Use Disorder in a General Medical Hospital: a case report and narrative literature review. Accepted to the Journal of Psychiatric Practice on March 17, 2016 [In Press].
https://www.ncbi.nlm.nih.gov/pubmed/28492461
Goldenberg M, IsHak WW, Danovitch I. Quality of Life and Recreational Cannabis Use. The American Journal on Addictions. Jan 2017; 26 (1), 8-25.
https://www.ncbi.nlm.nih.gov/pubmed/28000973
Goldenberg M, Reid MW, IsHak WW, Danovitch I. The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis. Drug Alcohol Depend. 2017 Mar 1;174:80-90. [Epub ahead of print]. PubMed PMID:28319753.
https://www.ncbi.nlm.nih.gov/pubmed/28319753
The Doctor’s show clip
https://www.thedoctorstv.com/videos/healthcare-workers-addicted-to-drugs
ESPN Interview:
http://www.espn.com/espnradio/losangeles/play?id=9646964
ABC News Story regarding Seymour Hoffman (about 1 min into story):
http://abcnews.go.com/WNT/video/philip-seymour-hoffmans-death-sheds-light-heroin-addiction-22368926
Featured in Wall Street Journal Article: Posted
Dr. Skipper quoted in Capital Weekly:
http://capitolweekly.net/drug-testing-doctors-prop-46-california7636/
Dr. Skipper quoted in Utah Desert News:
https://www.deseretnews.com/article/600138940/Patients-in-the-dark.html
White paper regarding drug testing:
http://www.williamwhitepapers.com/pr/2008RecentAlcoholTesting.pdf
https://www.deseretnews.com/article/600138940/Patients-in-the-dark.html
ESPN LA: Addiction Intervention and treatment of sports professionals. Radio show. Dr. Skipper
http://www.espn.com/espnradio/losangeles/play?id=9646964